Mounjaro (tirzepatide) and Ozempic (semaglutide) are both approved for diabetes, not weight loss specifically
Semaglutide is a GLP-1 receptor agonist that lowers blood sugar and reduces appetite by slowing gastric emptying and signaling fullness to your brain
Pharmaceuticals such as fluoroquinolones (e.g., ciprofloxacin), tetracyclines (e.g., tetracycline), sulfonamides (e.g., sulfamethoxazole), thiazide diuretics (e.g., chlorothiazide), NSAIDs (e.g., ketoprofen), and sulfonylurea-class anti-diabetics (Arimoto-Kobayashi 2014) are also reported as phototoxic substances
A researcher on 2.4mg semaglutide is not equivalent to a researcher on 12mg retatrutide, despite both being at their respective maximum doses
Masterjohn, Chris
This does not establish that general cosmetic use is safe, authorised or supported by long-term evidence